Search Login Register

Leukotriene E4 Summary

Description: A biologically active principle of SRS-A that is formed from LEUKOTRIENE D4 via a peptidase reaction that removes the glycine residue. The biological actions of LTE4 are similar to LTC4 and LTD4. (From Dictionary of Prostaglandins and Related Compounds, 1990)

Also Known As: Leukotriene E; Leukotriene E-4; Leukotrienes E; Leukotriene E 4; LTE4; 7,9,11,14-Eicosatetraenoic acid, 6-((2-amino-2-carboxyethyl)thio)-5-hydroxy-, (5S-(5R*,6S*(S*),7E,9E,11Z,14Z))-

Networked: 335 relevant articles (12 outcomes, 43 trials/studies) for this Bio-Agent

Key Diseases for which Leukotriene E4 is Relevant

  1. Asthma (Bronchial Asthma) : 7 outcomes 18 studies in 127 results
  2. Inflammation : 2 outcomes 1 study in 24 results
  3. Airway Obstruction (Choking) : 1 outcome 1 study in 10 results
  4. Chronic Obstructive Pulmonary Disease (COPD) : 1 outcome 1 study in 4 results
  5. Pulmonary Hypertension (Ayerza Syndrome) : 1 outcome 1 study in 3 results
Show All >>

Drugs Related to Leukotriene E4

  1. Leukotriene D4
  2. montelukast (Singulair)
  3. cysteinyl-leukotriene
  4. Leukotriene C4
  5. Leukotriene B4
  6. Eosinophil-Derived Neurotoxin
  7. Thromboxane B2
  8. Oxygen
  9. Carnitine (L-Carnitine)
  10. Histamine (Histamine Dihydrochloride)
Show All >>

Therapies Related to Leukotriene E4

  1. Ligation
  2. Coronary Artery Bypass (Coronary Artery Bypass Surgery)
  3. Oral Administration
  4. Tourniquets
  5. Transplants (Transplant)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.